Clinical Trials Logo

Inflammation clinical trials

View clinical trials related to Inflammation.

Filter by:

NCT ID: NCT05055362 Completed - Clinical trials for Overweight and Obesity

Effect a Honey, Spice-blended Baked Good Has on Salivary Inflammation Markers in Adults: a Pilot Study

Start date: September 22, 2021
Phase: N/A
Study type: Interventional

The purpose of this research is to determine the effect a spiced-infused baked good has on inflammatory biomarkers in adults who are overweight and/or who has chronic kidney disease. Participants will be involved for 10 days in this research study.

NCT ID: NCT05047029 Completed - Portal Hypertension Clinical Trials

Myocardial Fibrosis and Inflammation in Liver Cirrhosis

Start date: November 2, 2018
Phase:
Study type: Observational

The aim of this clinical prospective study is to assess structural and functional myocardial changes in patients with liver cirrhosis after implantation of transjugular intrahepatic portosystemic shunt (TIPS).

NCT ID: NCT05046145 Completed - Inflammation Clinical Trials

Effects of Non-invasive Neuromodulation on Food Desire, Chewing Pattern, Executive Functions and Oxidative Stress.

Start date: July 13, 2021
Phase: N/A
Study type: Interventional

From the change in self-regulation, memory is inhibited, allowing individuals to suppress or ignore unwanted or outdated associations and thus help to filter information relevant to dietary goals from irrelevant information. Provoking changes in neuroplasticity and cortical excitability contribute to the regulation of neural activity. Both could be modified by applying direct electrical current to the sensorimotor cortex, with polarity/current-dependent results, and their effect would last for hours after the end of stimulation. Transcranial Direct Current Stimulation (tDCS), translated into Portuguese as Estimulação Transcraniana por Corrente Contínua (ETCC) is a neuromodulating tool in which a low-intensity electrical current is applied to the scalp to modulate neuronal activity.

NCT ID: NCT05042167 Completed - Aging Clinical Trials

The Effect of Resistance Exercise on Inflammation in Young and Older Adults

Start date: October 1, 2021
Phase: N/A
Study type: Interventional

Healthy young and older adults will complete two trials in a randomized crossover counter-balanced order, including resistance exercise and sedentary control. During each trial, blood samples will be collected. The investigators hypothesized that an acute bout of resistance exercise exert different inflammation responses in young and older adults.

NCT ID: NCT05040698 Completed - Clinical trials for Hidradenitis Suppurativa

Study of the Effect of Fostamatinib Upon Cutaneous Inflammation in the Setting of Hidradenitis Suppurativa

Start date: October 1, 2021
Phase: Phase 2
Study type: Interventional

A 16 week exploratory, Proof of Concept study to evaluate the effect of Fostamatinib (12 weeks of treatment) upon cutaneous inflammation in Hidradenitis Suppurativa.

NCT ID: NCT05034315 Completed - Inflammation Clinical Trials

Effects of Whole Egg Consumption on Inflammation, Mood, and Recovery in Collegiate Female Gymnasts

Start date: July 1, 2018
Phase: N/A
Study type: Interventional

The objectives were to investigate the effects of whole egg consumption by collegiate female gymnasts on inflammatory markers, mood, and recovery.

NCT ID: NCT05034159 Completed - Pain Clinical Trials

CBT-I for Sleep, Pain, and Inflammation in Crohn's Disease

SPIN
Start date: October 22, 2021
Phase: N/A
Study type: Interventional

People with Crohn's disease often suffer from sleep problems. Long term, sleep problems may lead to more flares of Crohn's disease or other complications. In general, people with Crohn's disease also report that sleep problems can worsen symptoms of Crohn's disease the next day. In people with other medical problems, research has also shown that having sleep problems can make other things worse, such as pain and inflammation. In this study, the researchers want to understand the treatment of sleep problems in people with Crohn's disease, and what else might improve if sleep gets better. This study will use Cognitive Behavioral Therapy for Insomnia (CBT-I) to treat insomnia symptoms. CBT-I is the recommended treatment for insomnia and has been shown to improve sleep problems, pain, and inflammation in other groups of people. If this study is successful, it will contribute to understanding how to treat insomnia in people with Crohn's disease and how sleep impacts pain and inflammation. Long term, this information will be helpful in understanding how best to take care of people with Crohn's disease.

NCT ID: NCT05031663 Completed - Inflammation Clinical Trials

Effect of Almonds on Immune Strength and Response to Flu Vaccination in Overweight Men

Almond Immune
Start date: August 12, 2021
Phase: N/A
Study type: Interventional

This research study will test the effects of almonds on immune functions and immune response to influenza vaccine in overweight middle-aged men

NCT ID: NCT05021783 Completed - Inflammation Clinical Trials

The Relationship Between Magnetic Resonance Imaging (MRI) Scores and Sensory Testing in Axial Spondyloarthritis

Start date: February 1, 2021
Phase:
Study type: Observational [Patient Registry]

Axial spondyloarthritis is one of the most common rheumatic diseases and chronic pain and morning stiffness are the main complaints of these patients. Central sensitization is defined as increased response to normal or sub-threshold stimuli of central nervous system and its close relationship with many rheumatological diseases has been demonstrated in several studies. There is no method for the diagnosis of central sensitization is accepted as a gold standard. The clinical scales and quantitative sensory testing (QST) widely is used for this purpose widely. The most commonly used QST types include pressure pain threshold (PPT), temporal summation (TS) and conditioned pain modulation (CPM). The well-known scale used for the evaluation of central sensitization is the Central Sensitization Inventory (CSI) , developed in 2011 for detect central sensitization in chronic pain patients. In this study, it was aimed to investigate the relationship between QST and CSI and sacroiliac MRI changes.

NCT ID: NCT05017428 Completed - Clinical trials for Postprandial Inflammation

Absorption and Digestion Kinetics of Human Metabolites

Start date: April 8, 2021
Phase: N/A
Study type: Interventional

The purpose of this pilot study is to evaluate the effects oral supplementation with four human metabolites (spermidine, nicotinamide, palmitoylethanolamide (PEA), and oleoylethanolamide(OEA)) at varying doses on the circulating blood levels of these metabolites as well as their immediate effects on plasma functionality and postprandial inflammation. 5 young healthy subjects will participate in a four armed study consisting of a Placebo arm and a Low, Medium, and High Dose arm. Subjects will be given a standardized breakfast along with supplementation with either an escalating dose (Low: 1x, Medium: 2x, High: 3x) of a combination of spermidine, nicotinamide, PEA and OEA or a placebo control and a time course of their blood plasma will be collected after supplementation. Plasma samples will be assessed for their concentration of spermidine, nicotinamide, PEA, and OEA as well as their experimental and clinical functionalities including their anti-inflammatory, antioxidant, and cholesterol efflux abilities on primary human macrophage.